Last updated: October 25, 2026

Application No. 18/750,843

HIGH POTENCY EMULSIONS

Final Rejection

Filed

Jun 21, 2024

Priority

Apr 12, 2021 — provisional 63/173,965 +2 more

Examiner

BORI, IBRAHIM D

Art Unit

1629

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Vertosa Inc.

OA Round

4 (Final)

Interview Optional

— +39.0% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 44% grant rate with +39.0% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 615 resolved cases, 2023–2026

Examiner Intelligence

BORI, IBRAHIM D View full profile →

Grants 44% of resolved cases

Career Allowance Rate

270 granted / 615 resolved

-16.1% vs TC avg

Strong +39% interview lift

Without

With

+39.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

47 currently pending

Career history

668

Total Applications

across all art units

Statute-Specific Performance

§101

2.6%

-37.4% vs TC avg

§103

41.2%

+1.2% vs TC avg

§102

16.0%

-24.0% vs TC avg

§112

25.0%

-15.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 615 resolved cases

Prosecution Timeline

Show 10 earlier events

May 19, 2026

Applicant Interview (Telephonic)

May 19, 2026

Examiner Interview Summary

Jul 17, 2026

Response Filed

Aug 18, 2026

Final Rejection mailed

Aug 19, 2026

Interview Requested

Aug 24, 2026

Applicant Interview (Telephonic)

Aug 24, 2026

Examiner Interview Summary

Aug 24, 2026

Interview Requested

Precedent Cases

Applications granted by this same examiner with similar technology

15/734,781

Patent 12766113

CELLULAR RETINOID BINDING PROTEIN ANTAGONISTS AND USES THEREOF

5y 10m to grant Granted Oct 20, 2026

17/748,354

Patent 12766116

MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA, AND PATHOGENIC YEAST

4y 5m to grant Granted Oct 20, 2026

18/335,261

Patent 12766088

SKIN CARE EMULSION COMPOSITION WITH CLEAN POLYMERS AND EMULSIFIERS

3y 4m to grant Granted Oct 20, 2026

18/579,051

Patent 12759983

HYDROGENATED QUINOXALINES

2y 9m to grant Granted Oct 13, 2026

18/571,418

Patent 12753164

PYRIMIDINE-4,6-DIAMINE DERIVATIVE, A PREPARATION METHOD THEREFOR, AND A PHARMACEUTICAL APPLICATION THEREOF

2y 9m to grant Granted Oct 06, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6

Expected OA Rounds

44%

Grant Probability

83%

With Interview (+39.0%)

3y 5m (~1y 1m remaining)

Median Time to Grant

High

PTA Risk

Based on 615 resolved cases by this examiner. Grant probability derived from career allowance rate.

HIGH POTENCY EMULSIONS

Interview Optional

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

Strategy Recommendation AI-generated — please review before filing

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email